SCHEMBL5221010

SCHEMBL5221010

Cc1ccc(S(=O)(=O)NC(NS(=O)(=O)c2ccc(C)cc2)C(=O)OCc2ccccc2)cc1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 1/20 0.55
CA2 P00918 6/20 0.55
CA1 P00915 5/20 0.55
ALDH1A1 P00352 1/20 0.54
CA7 P43166 1/20 0.52
MAPT P10636 1/20 0.52
CA12 O43570 1/20 0.51
CYP1A2 P05177 1/20 0.51
CYP3A4 P08684 1/20 0.51
ATM Q13315 1/20 0.51
CA9 Q16790 1/20 0.51
L3MBTL1 Q9Y468 1/20 0.51
AR P10275 1/20 0.51
CTSL P07711 1/20 0.51
GAA P10253 1/20 0.50
HPN P05981 1/20 0.50
ST14 Q9Y5Y6 1/20 0.50
MMP9 P14780 2/20 0.49
ADAMTS4 O75173 1/20 0.48
MMP13 P45452 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30689105 0.88 ALDH1A1 (0.56) LMNACA2CA1ALDH1A1CA7
SCHEMBL30689121 0.86 ADAMTS4 (0.60) LMNACA2CA1ALDH1A1GAA
SCHEMBL30689103 0.86 CTSL (0.56) LMNACA2CA1ALDH1A1CA7
SCHEMBL20335059 0.86 CTSL (0.68) CA2ALDH1A1CA7MAPTCTSL
SCHEMBL20335058 0.86 CTSL (0.68) CA2ALDH1A1CA7MAPTCTSL
SCHEMBL30689139 0.86 ALDH1A1 (0.54) LMNACA2CA1ALDH1A1CA7
SCHEMBL29883707 0.84 CTSL (0.54) LMNACA2CA1ALDH1A1CA7
SCHEMBL30689129 0.84 ALDH1A1 (0.52) LMNACA2CA1ALDH1A1CA7
SCHEMBL7667779 0.83 MMP9 (0.52) LMNACA2CA1ALDH1A1CA7
SCHEMBL30689128 0.82 CTSL (0.63) CA2ALDH1A1CA7MAPTL3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1740549-A2 NOVEL IMIDAZOLES Warner-Lambert Company LLC (US) 2007-01-10 EP disclosed
US-20060287378-A1 Novel pyrroles and imidazoles WARNER-LAMBERT COMPANY LLC 2006-12-21 US disclosed
WO-2005105079-A2 NOVEL IMIDAZOLES WARNER-LAMBERT COMPANY LLC (US) 2005-11-10 WO disclosed
US-20050239857-A1 Novel imidazoles BOLTON GARY L 2005-10-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060287378-A1 Novel pyrroles and imidazoles PPIP5K2, PPIE, PPOX LMNA 4658/4885CA2 3832/4885CA1 3854/4885
US-20050239857-A1 Novel imidazoles HMGCR, HMGB2, HMGB3 LMNA 1034/4885CA2 3994/4885CA1 4433/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.